HomeCompareABBV vs RPM

ABBV vs RPM: Dividend Comparison 2026

ABBV yields 3.12% · RPM yields 2.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $44.6K in total portfolio value
10 years
ABBV
AbbVie Inc.
● Live price
3.12%
Share price
$213.22
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$104.7K
Annual income
$25,725.73
Full ABBV calculator →
RPM
RPM
● Live price
2.20%
Share price
$98.06
Annual div
$2.16
5Y div CAGR
39%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.1K
Annual income
$13,926.11
Full RPM calculator →

Portfolio growth — ABBV vs RPM

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABBVRPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABBV + RPM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABBV pays
RPM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABBV
Annual income on $10K today (after 15% tax)
$265.10/yr
After 10yr DRIP, annual income (after tax)
$21,866.87/yr
RPM
Annual income on $10K today (after 15% tax)
$187.23/yr
After 10yr DRIP, annual income (after tax)
$11,837.19/yr
At 15% tax rate, ABBV beats the other by $10,029.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABBV + RPM for your $10,000?

ABBV: 50%RPM: 50%
100% RPM50/50100% ABBV
Portfolio after 10yr
$82.4K
Annual income
$19,825.92/yr
Blended yield
24.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+20.1% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
RPM
Analyst Ratings
15
Buy
7
Hold
Consensus: Buy
Price Target
$122.33
+24.8% upside vs current
Range: $118.00 — $126.00
Altman Z
3.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABBV buys
7
RPM buys
9
PoliticianChamberTickerTypeAmountDate
David Taylor🏢 House$RPM▲ Buy$1,001 - $15,0002026-03-12
David Taylor🏢 House$RPM▲ Buy$1,001 - $15,0002026-03-11
David Taylor🏢 House$RPM▼ Sell$1,001 - $15,0002026-02-26
David Taylor🏢 House$RPM▲ Buy$1,001 - $15,0002026-01-29
David Taylor🏢 House$RPM▲ Buy$1,001 - $15,0002026-01-16
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-11-13
David Taylor🏢 House$RPM▲ Buy$1,001 - $15,0002025-11-11
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-31
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABBVRPM
Forward yield3.12%2.20%
Annual dividend / share$6.65$2.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR40.6%39%
Portfolio after 10y$104.7K$60.1K
Annual income after 10y$25,725.73$13,926.11
Total dividends collected$63.0K$35.9K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$256.15$122.33

Year-by-year: ABBV vs RPM ($10,000, DRIP)

YearABBV PortfolioABBV Income/yrRPM PortfolioRPM Income/yrGap
1← crossover$11,559$438.51$11,006$306.18+$553.00ABBV
2$13,494$640.86$12,214$437.77+$1.3KABBV
3$15,951$945.97$13,701$631.12+$2.3KABBV
4$19,152$1,413.89$15,579$919.62+$3.6KABBV
5$23,443$2,146.38$18,028$1,358.45+$5.4KABBV
6$29,391$3,321.96$21,332$2,042.13+$8.1KABBV
7$37,948$5,265.87$25,965$3,139.06+$12.0KABBV
8$50,795$8,596.74$32,745$4,963.35+$18.1KABBV
9$71,034$14,549.41$43,169$8,131.59+$27.9KABBV
10$104,715$25,725.73$60,117$13,926.11+$44.6KABBV

ABBV vs RPM: Complete Analysis 2026

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →

RPMMaterials

RPM International Inc. manufactures, markets, and sells specialty chemicals for the industrial, specialty, and consumer markets worldwide. It offers waterproofing, coating, and institutional roofing systems; sealants, air barriers, tapes, and foams; residential home weatherization systems; roofing and building maintenance services; sealing and bonding, subfloor preparation, flooring, and glazing solutions; resin flooring systems, polyurethane, MMA waterproof, epoxy floor paint and coatings, concrete repair, and protection products; solutions for fire stopping and intumescent steel coating, and manufacturing industry; rolled asphalt roofing materials and chemical admixtures; concrete and masonry admixtures, concrete fibers, curing and sealing compounds, structural grouts and mortars, epoxy adhesives, injection resins, polyurethane foams, floor hardeners and toppings, joint fillers, industrial and architectural coatings, decorative color/stains/stamps, and restoration materials; insulated building cladding materials; and concrete form wall systems. It also provides polymer flooring systems; fiberglass reinforced plastic gratings and shapes; corrosion-control coating, containment and railcar lining, fire and sound proofing, and heat and cryogenic insulation products; specialty construction products; amine curing agents, reactive diluents, and epoxy resins; fluorescent colorants and pigments; shellac-based-specialty and marine coatings; fire and water damage restoration, carpet cleaning, and disinfecting products; fuel additives; wood treatments, and touch-up products; and nail enamels, polishes, and coating components. In addition, it offers paint contractors and the DIYers solutions, concrete restoration and flooring, metallic and faux finish coatings, cleaners, and hobby paints and cements; and caulk, sealant, adhesive, insulating foam, spackling, glazing, patch, and repair products. The company was incorporated in 1947 and is headquartered in Medina, Ohio.

Full RPM Calculator →
📬

Get this ABBV vs RPM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMYABBV vs LLYABBV vs SCHDABBV vs JEPIABBV vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.